Literature DB >> 8797462

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.

L H Visser1, F G van der Meché, J Meulstee, P P Rothbarth, B C Jacobs, P I Schmitz, P A van Doorn.   

Abstract

Guillain-Barré syndrome (GBS) is usually preceded by infections, in particular cytomegalovirus (CMV) and Campylobacter jejuni infection. We studied the clinical and electrophysiologic features of 20 CMV-associated GBS patients and compared the findings with earlier established data of C. jejuni-related GBS patients (n = 43) and of GBS patients without these infections (n = 71). The patients all participated in the Dutch GBS trial in which we compared the effect of intravenous immune globulins and plasma exchange. We demonstrate that CMV-related GBS patients have a different clinical pattern in comparison with the other two GBS groups. They are significantly younger, initially have a severe course indicated by a high frequency of respiratory insufficiency, and often develop cranial nerve involvement and severe sensory loss. This is in contrast to C. jejuni infection, which is associated with motor GBS. Both infections are associated with delayed recovery compared with the GBS patients without these infections.

Entities:  

Mesh:

Year:  1996        PMID: 8797462     DOI: 10.1212/wnl.47.3.668

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 2.  Mechanisms for the induction of autoimmunity by infectious agents.

Authors:  K W Wucherpfennig
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Bilateral abducens palsy in a case of cytomegalovirus-associated Guillain-Barré syndrome.

Authors:  Masahiko Kishi; Ryuji Sakakibara; Emina Ogawa; Fuyuki Tateno; Osamu Takahashi; Michiaki Koga
Journal:  Neurol Sci       Date:  2011-07-22       Impact factor: 3.307

Review 4.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

Review 5.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

6.  Peripheral neuropathies: clinical prognostic scales in Guillain-Barré syndrome.

Authors:  Nortina Shahrizaila; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2011-06-21       Impact factor: 42.937

Review 7.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

Review 8.  Respiratory dysfunction in Guillain-Barré Syndrome.

Authors:  David Orlikowski; Hélène Prigent; Tarek Sharshar; Frédéric Lofaso; Jean Claude Raphael
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 9.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

10.  Cytomegalovirus disease with Guillain-Barré syndrome in a cadaver renal allograft recipient: cause or coincidence.

Authors:  Sai Ram R Keithi-Reddy; Rajasekhara M Chakravarthi; Shaista M Hussaini; Rohini R Venkatapuram; J M K Murthy
Journal:  Int Urol Nephrol       Date:  2007-04-21       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.